INTERLEUKIN-2 RECEPTOR-TARGETED CYTOTOXICITY - RECEPTOR-BINDING REQUIREMENTS FOR ENTRY OF A DIPHTHERIA TOXIN-RELATED INTERLEUKIN-2 FUSION PROTEIN INTO CELLS

被引:100
作者
WATERS, CA
SCHIMKE, PA
SNIDER, CE
ITOH, K
SMITH, KA
NICHOLS, JC
STROM, TB
MURPHY, JR
机构
[1] UNIV HOSP BOSTON,DEPT MED,88 E NEWTON ST,BOSTON,MA 02118
[2] SERAGEN INC,HOPKINTON,MA
[3] UNIV HOSP BOSTON,EVANS DEPT CLIN RES,BOSTON,MA 02118
[4] BOSTON UNIV,MED CTR,BOSTON,MA 02215
[5] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT GEN SURG,HOUSTON,TX 77030
[6] DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,IMMUNOL RES LAB,HANOVER,NH 03756
[7] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,CHARLES A DANA RES INST,THORNDIKE LAB,BOSTON,MA 02215
关键词
D O I
10.1002/eji.1830200412
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The receptor binding requirements for entry of the NAD+ ADP‐ribosyltransferase component of DAB486‐IL 2 into target cells were examined. Experiments utilizing cell lines bearing either high‐affinity or individual subunits of the interleukin 2 receptor (IL 2R) as well as human peripheral blood mononuclear cells with natural killer activity demonstrate that the high‐affinity receptor facilitates delivery of fragment A from DAB486‐IL 2 to the cytosol approximately 1000 times more efficiently than either the intermediate‐(p75) or low‐affinity (p55) forms of the IL 2R. We show that elongation factor 2 (EF‐2) in these cells is not quantitatively or qualitatively altered indicating that the relative resistance to intoxication displayed by IL 2R variant cell lines cannot be attributed to an altered intracellular target of the hybrid toxin. We also demonstrate that an alteration in the binding of DAB486‐IL 2 to the p75 subunit of the IL 2R may account for the selective cytotoxicity of DAB486‐IL 2 for cells bearing the heterodimeric high‐affinity IL 2R. Copyright © 1990 Wiley‐VCH Verlag GmbH & Co. KGaA, Weinheim
引用
收藏
页码:785 / 791
页数:7
相关论文
共 41 条
  • [1] INTERLEUKIN-2 RECEPTOR TARGETED CYTO-TOXICITY INTERLEUKIN-2 RECEPTOR MEDIATED ACTION OF A DIPHTHERIA-TOXIN RELATED INTERLEUKIN-2 FUSION PROTEIN
    BACHA, P
    WILLIAMS, DP
    WATERS, C
    WILLIAMS, JM
    MURPHY, JR
    STROM, TB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (02) : 612 - 622
  • [2] SEVERE HERPESVIRUS INFECTIONS IN AN ADOLESCENT WITHOUT NATURAL-KILLER CELLS
    BIRON, CA
    BYRON, KS
    SULLIVAN, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (26) : 1731 - 1735
  • [3] SELECTIVE KILLING OF HIV-INFECTED CELLS BY RECOMBINANT HUMAN CD4-PSEUDOMONAS EXOTOXIN HYBRID PROTEIN
    CHAUDHARY, VK
    MIZUKAMI, T
    FUERST, TR
    FITZGERALD, DJ
    MOSS, B
    PASTAN, I
    BERGER, EA
    [J]. NATURE, 1988, 335 (6188) : 369 - 372
  • [4] ACTIVITY OF A RECOMBINANT FUSION PROTEIN BETWEEN TRANSFORMING GROWTH-FACTOR TYPE-ALPHA AND PSEUDOMONAS TOXIN
    CHAUDHARY, VK
    FITZGERALD, DJ
    ADHYA, S
    PASTAN, I
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (13) : 4538 - 4542
  • [5] IDENTIFICATION OF SPECIFIC RESIDUES OF HUMAN INTERLEUKIN-2 THAT AFFECT BINDING TO THE 70-KDA SUBUNIT (P70) OF THE INTERLEUKIN-2 RECEPTOR
    COLLINS, L
    TSIEN, WH
    SEALS, C
    HAKIMI, J
    WEBER, D
    BAILON, P
    HOSKINGS, J
    GREENE, WC
    TOOME, V
    JU, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (20) : 7709 - 7713
  • [6] A 2ND HUMAN INTERLEUKIN-2 BINDING-PROTEIN THAT MAY BE A COMPONENT OF HIGH-AFFINITY INTERLEUKIN-2 RECEPTORS
    DUKOVICH, M
    WANO, Y
    THUY, LTB
    KATZ, P
    CULLENS, BR
    KEHRL, JH
    GREENE, WC
    [J]. NATURE, 1987, 327 (6122) : 518 - 522
  • [7] FORD CHJ, 1986, CANCER CHEMOTH PHARM, V17, P197
  • [8] HIGH-AFFINITY RECEPTOR-MEDIATED INTERNALIZATION AND DEGRADATION OF INTERLEUKIN-2 IN HUMAN T-CELLS
    FUJII, M
    SUGAMURA, K
    SANO, K
    NAKAI, M
    SUGITA, K
    HINUMA, Y
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (03) : 550 - 562
  • [9] GHOSE T, 1987, CRC CR REV THER DRUG, V3, P263
  • [10] SPONTANEOUS HUMAN T-CELL CYTOTOXICITY AGAINST MURINE HYBRIDOMAS EXPRESSING THE OKT3 MONOCLONAL-ANTIBODY - COMPARISON WITH NATURAL-KILLER CELL-ACTIVITY
    ITOH, K
    BALCH, CM
    PLATSOUCAS, CD
    [J]. CELLULAR IMMUNOLOGY, 1987, 108 (02) : 313 - 322